Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patients
- 1 February 1979
- journal article
- research article
- Published by Elsevier
- Vol. 15 (2) , 197-204
- https://doi.org/10.1016/0014-2964(79)90060-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A phase II study of autologous irradiated tumor cells plus BCG in patients with metastatic malignant melanomaCancer, 1977
- Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.Journal of Clinical Investigation, 1977
- Effect of treatment with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) or 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) plus vincristine (NSC-67574) on lymphocyte reactivity of melanoma patientsCancer Immunology, Immunotherapy, 1977
- Sequentialin vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donorsInternational Journal of Cancer, 1975
- Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant MelanomaBMJ, 1971
- Autoimmunization with Irradiated Tumour Cells in Human Malignant MelanomaBMJ, 1970
- A MICROASSAY FOR CELL-MEDIATED IMMUNITYTransplantation, 1970
- Studies on the Suppression of Immune Responses by the Periwinkle Alkaloids Vincristine and Vinblastine*Journal of Clinical Investigation, 1964
- THE EFFECT OF 6-MERCAPTOPURINE ON PRIMARY AND SECONDARY IMMUNE RESPONSES *Journal of Clinical Investigation, 1959